Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$17.49 USD
+0.17 (0.98%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $17.48 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth F Momentum C VGM
Orthofix (OFIX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.73 | $27.20 | $18.00 | 25.46% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Orthofix comes to $21.73. The forecasts range from a low of $18.00 to a high of $27.20. The average price target represents an increase of 25.46% from the last closing price of $17.32.
Analyst Price Targets (3 )
Broker Rating
Orthofix currently has an average brokerage recommendation (ABR) of 2.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, two are Strong Buy, representing 40% of all recommendations. A month ago, Strong Buy represented 40%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.20 | 2.20 | 2.20 | 2.20 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | JMP Securities | David L Turkaly | Hold | Hold |
6/16/2024 | Not Identified | Not Identified | Hold | Hold |
5/8/2024 | Roth Capital Partners | Jason Wittes | Hold | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.20 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 5 |
Average Target Price | $21.73 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | -0.14 |